Maven Securities’s Avidity Biosciences RNAM Stock Holding History

Maven Securities’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-95,055	Closed	-$6.86M	–	527
2025 Q4	$6.86M	Buy	95,055 +35,055	+58%	+$2.26M	0.15%	149
2025 Q3	$2.61M	Buy	+60,000	New	+$2.43M	0.06%	257

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Maven Securities's RNAM Position: Q1 2026 in Review

Maven Securities sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 95,055 shares — an estimated $6.86M sold.

Maven Securities first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $6.86M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Maven Securities reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Maven Securities sold 95,055 Avidity Biosciences shares in Q1 2026, an estimated $6.86M.
Maven Securities first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
Maven Securities's Avidity Biosciences position peaked at $6.86M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.